These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 150082)

  • 1. Donor-specific preformed B-lymphocyte antibodies and mixed lymphocyte culture (MLC) blocking in cadaver renal allograft recipients.
    Ettenger RB; Opelz G; Walker J; Terasaki PI; Malekzadeh MH; Pennisi AJ; Uittenbogaart CH; Fine RN
    Transplant Proc; 1978 Jun; 10(2):479-81. PubMed ID: 150082
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibodies to donor B lymphocytes and mixed lymphocyte culture blocking in cadaveric renal transplantation.
    Ettenger RB; Opelz G; Walker J; Terasaki PI; Uittenbogaart C; Pennisi AJ; Malekzadeh MH; Fine RN
    Transplantation; 1978 Apr; 25(4):169-72. PubMed ID: 147530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibodies to donor B lymphocytes and autoantibodies in renal transplantation.
    Ettenger RB; Robinson BJ; Uittenbogaart CH; Hacker TA; Pennisi AJ; Malekzadeh MH; Fine RN
    Transplant Proc; 1979 Mar; 11(1):401-3. PubMed ID: 377666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved renal allograft survival using the mixed lymphocyte culture for selection of nonidentical living related donors.
    Riggio RR; Saal SD; Katz EB; Tapia L; White R; Chami J; Sheigh JS; Sullivan JF; Stenzel KH; Stubenbord WT; Whitsell JC; Rubin AL
    Trans Am Soc Artif Intern Organs; 1975; 21():90-5. PubMed ID: 1096421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mixed leucocyte culture blocking factor activity in allograft recipients and its role in the clinical outcome of human cadaveric renal allografts.
    Sengar DP; Rashid A; Harris JE
    Clin Exp Immunol; 1975 Dec; 22(3):409-18. PubMed ID: 131667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship of donor-specific mixed lymphocyte culture reactivity to graft function in recipients of cadaveric renal allografts.
    Rashid A; Sengar DP; Harris JE
    Clin Exp Immunol; 1979 Jun; 36(3):521-7. PubMed ID: 158449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Significance of HLA-DR matching and of B cell crossmatch tests in vitro and in cadaver renal transplantation.
    Albrechtsen D; Arnesen E; Solheim BG; Thorsby E
    Transplant Proc; 1979 Mar; 11(1):743-7. PubMed ID: 156432
    [No Abstract]   [Full Text] [Related]  

  • 8. [The significance of mixed lymphocyte culture and mitogen-stimulated culture for kidney transplantation (author's transl)].
    Hajek-Rosenmayr A; Wolf A
    Wien Klin Wochenschr; 1981 Jul; 93(14):457-60. PubMed ID: 6455859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MLC inhibitory alloantibodies and outcome of kidney allografts.
    Suciu-Foca N; Hardy M; Kiamar M; Weiner J; Susinno E; Molinaro AP; Jacob J; Reemtsma K
    Transplant Proc; 1978 Jun; 10(2):493-5. PubMed ID: 150083
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of positive crossmatch against donor B lymphocytes in kidney transplantation: a prospective one-center study.
    Hourmant M; Bignon JD; Cesbron A; Soulillou JP
    Clin Transpl; 1990; ():301-9. PubMed ID: 2103154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravenous immunoglobulin and thymoglobulin facilitate kidney transplantation in complement-dependent cytotoxicity B-cell and flow cytometry T- or B-cell crossmatch-positive patients.
    Akalin E; Ames S; Sehgal V; Fotino M; Daly L; Murphy B; Bromberg JS
    Transplantation; 2003 Nov; 76(10):1444-7. PubMed ID: 14657683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alloantibodies and the outcome of cadaver kidney allografts.
    Vasilescu ER; Ho EK; Colovai AI; Vlad G; Foca-Rodi A; Markowitz GS; D'Agati V; Hardy MA; Ratner LE; Suciu-Foca N
    Hum Immunol; 2006 Aug; 67(8):597-604. PubMed ID: 16916655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-B lymphocytotoxins in renal-allograft rejection.
    Ettenger RB; Terasaki PI; Ting A; Malekzadeh MH; Pennisi AJ; Uittenbogaart C; Garrison R; Fine RN
    N Engl J Med; 1976 Aug; 295(6):305-9. PubMed ID: 778617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Crossmatch procedures used in organ transplantation.
    Gebel HM; Lebeck LK
    Clin Lab Med; 1991 Sep; 11(3):603-20. PubMed ID: 1934966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A rapid MLC test for selection of allograft recipients for cadaveric kidneys.
    Butt KM; Parsa I; Kountz SL
    Surg Forum; 1973; 24():272-3. PubMed ID: 4282520
    [No Abstract]   [Full Text] [Related]  

  • 16. Circulating antibodies in allograft recipients.
    Revillard JP; Betuel H
    Adv Nephrol Necker Hosp; 1975; 5():257-81. PubMed ID: 127522
    [No Abstract]   [Full Text] [Related]  

  • 17. Relevance of different antibody detection methods for the prediction of antibody-mediated rejection and deceased-donor kidney allograft survival.
    Vlad G; Ho EK; Vasilescu ER; Colovai AI; Stokes MB; Markowitz GS; D'Agati VD; Cohen DJ; Ratner LE; Suciu-Foca N
    Hum Immunol; 2009 Aug; 70(8):589-94. PubMed ID: 19375470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Positive cross-match for B-lymphocyte antigens (IA like) and kidney allograft behaviour.
    Soulillou JP; Guenel J; Peyrat MA
    Biomedicine; 1977 Jul; 27(5):183-4. PubMed ID: 336109
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of cell-mediated lympholysis and mixed lymphocyte culture in the immunologic evaluation for renal transplantation.
    Harmon WE; Parkman R; Lavin PT; Grupe WE; Ingelfinger JR; Yunis EJ; Levey RH
    J Immunol; 1982 Oct; 129(4):1573-7. PubMed ID: 6213715
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IgG donor-specific crossmatches are not associated with graft rejection or poor graft survival after liver transplantation. An assessment by cytotoxicity and flow cytometry.
    Donaldson PT; Thomson LJ; Heads A; Underhill JA; Vaughan RW; Rolando N; Williams R
    Transplantation; 1995 Nov; 60(9):1016-23. PubMed ID: 7491675
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.